Wide Ranks

BIO

Bio-Rad Laboratories, Inc.

338.48

Top Statistics
Market Cap 9 B Forward PE 29.51 Revenue Growth 2.80 %
Current Ratio 6.14 Trailing PE 0.0000 Earnings Growth 541.20 %
Profit Margins -30.18 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 19.11 Enterprise / Revenue 3.58 Price To Sales Trailing12 Months 3.67
Profitability
Profit Margins -30.18 % Operating Margins 9.94 %
Balance Sheet
Total Cash 1 B Total Cash Per Share 57.95 Total Debt 1 B
Total Debt To Equity 18.54 Current Ratio 6.14 Book Value Per Share 267.46
All Measures
Short Ratio 264.00 % Message Board Id finmb_255743 Fax 510 741 5817
Shares Short Prior Month 823113 Return On Equity -0.0979 City Hercules
Uuid 6cebea0a-fe88-3cb6-af78-b738eb7ab8a1 Previous Close 337.73 First Trade Date Epoch Utc 320 M
Book Value 267.46 Beta 0.9360 Total Debt 1 B
Volume 127564 Price To Book 1.27 Last Split Date 1 B
Fifty Two Week Low 262.12 Total Cash Per Share 57.95 Total Revenue 2 B
Shares Short Previous Month Date 1 B Target Median Price 410.00 Max Age 86400
Sand P52 Week Change 0.3133 Operating Margins 9.94 % Target Mean Price 402.33
Net Income To Common -778689984 Ask 346.96 Short Percent Of Float 0.0302
Implied Shares Outstanding 28 M Last Fiscal Year End 1 B Trailing Peg Ratio None
Average Daily Volume10 Day 222860 Average Volume10days 222860 Total Cash 1 B
Next Fiscal Year End 1 B Revenue Per Share 90.81 Held Percent Insiders 0.1557
Ebitda Margins 18.74 % Trailing PE 0.0000 Date Short Interest 1 B
Most Recent Quarter 1 B Regular Market Previous Close 337.73 Target Low Price 315.00
Gmt Off Set Milliseconds -18000000 Fifty Day Average 340.63 Open 341.75
Free Cashflow 91 M State CA Dividend Yield 0.00 %
Return On Assets 0.0186 Time Zone Short Name EST Trailing Eps -28.09
Day Low 336.77 Address1 1000 Alfred Nobel Drive Shares Outstanding 22 M
Price Hint 2 Target High Price 469.00 Website https://www.bio-rad.com
52 Week Change 0.1101 Average Volume 296076 Earnings Quarterly Growth 514.70 %
Forward Eps 11.65 Recommendation Key none Compensation As Of Epoch Date 1 B
Quick Ratio 420.80 % Last Split Factor 2:1 Regular Market Day High 345.49
Is_sp_500 False Profit Margins -30.18 % Debt To Equity 18.54
Fifty Two Week High 387.99 Day High 345.49 Shares Short 524437
Regular Market Open 341.75 Industry Key medical-devices Bid 306.00
Earnings Growth 541.20 % Enterprise To Revenue 3.58 Revenue Growth 2.80 %
Shares Percent Shares Out 0.0187 Operating Cashflow 412 M Currency USD
Time Zone Full Name America/New_York Market Cap 9 B Is_nasdaq_100 False
Zip 94547 Quote Type EQUITY Industry Medical Devices
Long Name Bio-Rad Laboratories, Inc. Regular Market Day Low 336.77 Held Percent Institutions 0.7996
Current Price 338.48 Enterprise To Ebitda 19.11 Financial Currency USD
Current Ratio 6.14 Gross Margins 54.54 % Industry Disp Medical Devices
Number Of Analyst Opinions 6 Country United States Float Shares 19 M
Two Hundred Day Average 317.51 Enterprise Value 9 B Price To Sales Trailing12 Months 3.67
Forward PE 29.51 Regular Market Volume 127564 Ebitda 483 M
Exchange NYQ
Go to Yahoo Finance Go to Seeking Alpha 
Bio-Rad Laboratories, Inc. manufactures and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America.

It operates through two segments, Life Science and Clinical Diagnostics.

The company develops, manufactures, and markets instruments, systems, reagents, and consumables to separate, purify, characterize, and quantitate biological materials such as cells, proteins, and nucleic acids for proteomics, genomics, biopharmaceutical production, cellular biology, and food safety markets.

It also designs, manufactures, markets, and supports test systems, informatics systems, test kits, and specialized quality controls for hospitals, diagnostic reference, transfusion, and physician office laboratories.

The company offers its products through its direct sales force, as well as through distributors, agents, brokers, and resellers.

Bio-Rad Laboratories, Inc. was founded in 1952 and is headquartered in Hercules, California.